The human immunodeficiency virus (HIV), the causative agent of AIDS, is complex retrovirus with levels of control imparted by regulatory and accessory proteins not found in simple retroviruses. It is important to continue to study these regulatory/accessory proteins because they offer a window into control of normal host cell processes. This grant focuses on the interaction of the cell cycle progression by causing cells to accumulate in the G2 phase of the cell cycle and to a subsequent block in mitosis. It has been unclear why this would be beneficial for the virus. In this proposal, we seek to understand the mechanism of action of Vpr and resolve the question of the selective advantage this confers on the virus. We will critically test the hypothesis that the selection for G2 arrest is due to increased virus production in the G2 phase of the cell cycle in cells with a short half-life. This will be done by setting up mixed infections between viruses that do or do not cause cell cycle arrest, and then measuring the relative fitness of the viruses under conditions where the life-span of the infected cells is experimentally manipulated. To understand the mechanism of Vpr-induced G2 arrest, we will determine if the interaction between Vpr and the cell cycle regulators, Cdc25, can explain the effects of Vr on cell cycle arrest. This will be done with biochemical and genetic experiments to define the nature and importance of inhibition of Cdc25 activity by Vpr. Finally, we will characterize the effect of Vpr on segregation of chromosomes in mitosis. It is anticipated that these results will allow us to more fully understand the interaction of the virus with its host.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Method to Extend Research in Time (MERIT) Award (R37)
Project #
2R37AI030927-11
Application #
6312406
Study Section
Special Emphasis Panel (ZRG1-AARR-2 (02))
Program Officer
Young, Janet M
Project Start
1991-08-01
Project End
2006-04-30
Budget Start
2001-06-01
Budget End
2002-04-30
Support Year
11
Fiscal Year
2001
Total Cost
$410,875
Indirect Cost
Name
Fred Hutchinson Cancer Research Center
Department
Type
DUNS #
075524595
City
Seattle
State
WA
Country
United States
Zip Code
98109
OhAinle, Molly; Helms, Louisa; Vermeire, Jolien et al. (2018) A virus-packageable CRISPR screen identifies host factors mediating interferon inhibition of HIV. Elife 7:
Malfavon-Borja, Ray; Sawyer, Sara L; Wu, Lily I et al. (2013) An evolutionary screen highlights canonical and noncanonical candidate antiviral genes within the primate TRIM gene family. Genome Biol Evol 5:2141-54
Tareen, Semih U; Emerman, Michael (2011) Human Trim5? has additional activities that are uncoupled from retroviral capsid recognition. Virology 409:113-20
Tareen, Semih U; Sawyer, Sara L; Malik, Harmit S et al. (2009) An expanded clade of rodent Trim5 genes. Virology 385:473-83
Voronin, Yegor; Holte, Sarah; Overbaugh, Julie et al. (2009) Genetic drift of HIV populations in culture. PLoS Genet 5:e1000431
OhAinle, Molly; Kerns, Julie A; Li, Melody M H et al. (2008) Antiretroelement activity of APOBEC3H was lost twice in recent human evolution. Cell Host Microbe 4:249-59
Lin, Tsai-Yu; Emerman, Michael (2008) Determinants of cyclophilin A-dependent TRIM5 alpha restriction against HIV-1. Virology 379:335-41
Sawyer, Sara L; Emerman, Michael; Malik, Harmit S (2007) Discordant evolution of the adjacent antiretroviral genes TRIM22 and TRIM5 in mammals. PLoS Pathog 3:e197
Voronin, Yegor; Chohan, Bhavna; Emerman, Michael et al. (2007) Primary isolates of human immunodeficiency virus type 1 are usually dominated by the major variants found in blood. J Virol 81:10232-41
Yamashita, Masahiro; Emerman, Michael (2006) Retroviral infection of non-dividing cells: old and new perspectives. Virology 344:88-93

Showing the most recent 10 out of 25 publications